Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SMOF vs Intralipid in Home Parenteral Nutrition
NCT02796833Phase 4Completed
- Start
- Mar 2016
- Primary completion
- Dec 2019
- Modality
- Lipid-based Nanoparticles
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of SMOFlipid in intestinal failure (IF) (2 arms). Primary endpoint: Change in Alanine Transaminase at 13 months. Started Mar 2016; status: completed.
02
Drugs
SMOFlipid
03
Conditions
intestinal failure (IF)
Beyond the preview
Go deeper on NCT02796833.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02796833.